Coloplast Corp – FDA 483, Apr 11, 2024
Coloplast Manufacturing US, LLC in North Mankato, MN, a manufacturer of OTC drugs, was cited for three significant deficiencies during an FDA inspection. Observations included a lack of temperature mapping studies for drug product storage, absence of microbiological testing for Burkholderia Cepacia Complex in water used for non-sterile products, and inadequate written procedures for the site's Quality Unit responsibilities. These issues indicate potential risks to drug product quality and purity.
- Person
ID · e97c16e6-72df-4a29-b416-f7562e784e36
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.